Atorvastatin enhances hypothermia-induced neuroprotection after stroke

Journal of the Neurological Sciences

Volumn 275, Issue 1-2, 2008, Pages 64-68

  Lee, Seung Hoon ^a,b   Kim, Yoon Hee ^a,b   Kim, Young Ju ^a,b   Yoon, Byung Woo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Combination therapy; Hypothermia; Ischemia; Neuroprotection; Statin

Indexed keywords

ATORVASTATIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; INDUCED HYPOTHERMIA; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; ANTIGENS, CD11B; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOTHERMIA, INDUCED; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; NITRIC OXIDE SYNTHASE TYPE II; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; STROKE;

EID: 55649123457     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.07.029     Document Type: Article

References (34)

1. Endres M., Laufs U., Huang Z., Nakamura T., Huang P., Moskowitz M.A., et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95 (1998) 8880-8885
2. Sironi L., Cimino M., Guerrini U., Calvio A.M., Lodetti B., Asdente M., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 23 (2003) 322-327
3. Laufs U., Gertz K., Huang P., Nickenig G., Bohm M., Dirnagl U., et al. Atorvastatin upregulates type iii nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31 (2000) 2442-2449
4. Busto R., Dietrich W.D., Globus M.Y., Valdes I., Scheinberg P., and Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7 (1987) 729-738
5. Yenari M.A., Iwayama S., Cheng D., Sun G.H., Fujimura M., Morita-Fujimura Y., et al. Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab 22 (2002) 29-38
6. Iadecola C., Goldman S.S., Harder D.R., Heistad D.D., Katusic Z.S., Moskowitz M.A., et al. Recommendations of the national heart, lung, and blood institute working group on cerebrovascular biology and disease. Stroke 37 (2006) 1578-1581
7. Meairs S., Wahlgren N., Dirnagl U., Lindvall O., Rothwell P., Baron J.C., et al. Stroke research priorities for the next decade-a representative view of the European Scientific Community. Cerebrovasc Dis 22 (2006) 75-82
8. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4 (2003) 399-415
9. del Zoppo G.J., and Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23 (2003) 879-894
10. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West Of Scotland COronary Prevention Study group. N Engl J Med 333 (1995) 1301-1307
11. Sever P.S., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361 (2003) 1149-1158
12. Lee S.H., Kim M., Kim Y.J., Kim Y.A., Chi J.G., Roh J.K., et al. Ischemic intensity influences the distribution of delayed infarction and apoptotic cell death following transient focal cerebral ischemia in rats. Brain Res 956 (2002) 14-23
13. Lee S.H., Kwon H.M., Kim Y.J., Lee K.M., Kim M., and Yoon B.W. Effects of hsp70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke 35 (2004) 2195-2199
14. Lee S.H., Kim Y.J., Lee K.M., Ryu S., and Yoon B.W. Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience (2007)
15. Asahi M., Huang Z., Thomas S., Yoshimura S., Sumii T., Mori T., et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 25 (2005) 722-729
16. Yrjanheikki J., Koistinaho J., Kettunen M., Kauppinen R.A., Appel K., Hull M., et al. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 1052 (2005) 174-179
17. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., and Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10 (1990) 290-293
18. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
19. Amarenco P., and Tonkin A.M. Statins for stroke prevention: disappointment and hope. Circulation 109 (2004) III44-III49
20. Amin-Hanjani S., Stagliano N.E., Yamada M., Huang P.L., Liao J.K., and Moskowitz M.A. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32 (2001) 980-986
21. Zhou M.S., Jaimes E.A., and Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Hypertension 44 (2004) 186-190
22. Jung K.H., Chu K., Jeong S.W., Han S.Y., Lee S.T., Kim J.Y., et al. Hmg-coa reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35 (2004) 1744-1749
23. Mayer S.A., Brun N.C., Begtrup K., Broderick J.P., Davis S.M., Diringer M.N., et al. Investigators obotF. Randomised, placebo-controlled, double-blind phase III study to assess rFVIIa efficacy in acute intracerebral hemorrhage: The fast trial. European Stroke Conference, Glasgow, UK (2007). http://www.esc-archive.eu/glasgow07/ESC07_FP_.pdf http://www.esc-archive.eu/glasgow07/ESC07_FP_.pdf
24. Takata T., Nabetani M., and Okada Y. Effects of hypothermia on the neuronal activity, [Ca2+]i accumulation and atp levels during oxygen and/or glucose deprivation in hippocampal slices of guinea pigs. Neurosci Lett 227 (1997) 41-44
25. Chopp M., Knight R., Tidwell C.D., Helpern J.A., Brown E., and Welch K.M. The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: comparison to normothermia and hyperthermia. J Cereb Blood Flow Metab 9 (1989) 141-148
26. Dietrich W.D., Busto R., Halley M., and Valdes I. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol 49 (1990) 486-497
27. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (2004) 685-696
28. LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
29. Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
30. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
31. Amarenco P., Bogousslavsky J., Callahan III A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
32. Yeung A.C., and Tsao P. Statin therapy: beyond cholesterol lowering and antiinflammatory effects. Circulation 105 (2002) 2937-2938
33. Lees K.R., Zivin J.A., Ashwood T., Davalos A., Davis S.M., Diener H.C., et al. NXY-059 for acute ischemic stroke. N Engl J Med 354 (2006) 588-600
34. Shuaib A., Lees K.R., Grotta J., Lyden P., Da'valos A., Davis S.M., et al. Saint II: results of the second randomized, multicenter, placebo-controlled, double-blind study of NXY-059 treatment in patients with acute ischemic stroke. Stroke 38 (2005) 2007 International Stroke Conference [abstract]